TORONTO, Jan. 15, 2020 /CNW/ - National Access
Cannabis Corp. (TSXV: META) d/b/a Meta Growth
("Meta Growth", "META" or the
"Company"), Canada's largest publicly traded recreational
cannabis retailer by revenue1, announces the transaction
originally announced on November 1,
2019 will not be proceeding, and that the agreement to sell
META's medical cannabis clinics division to Evergreen Pacific
Insurance Corporation has been terminated effective
immediately.
"META's focus remains on maintaining a leadership position
within the retail recreational cannabis industry and we are
committed to finding the right home for our established medical
clinics division. We are confident that a transaction which
is beneficial to our employees, clients, and shareholders will
occur in the future," said Mark
Goliger, CEO of Meta Growth.
About Meta Growth
Meta Growth is a leader in secure, safe and responsible access
to legal recreational cannabis in Canada. Through its Canada-wide network of Meta Cannabis Co.™,
Meta Cannabis Supply Co.™ and NewLeaf Cannabis™ recreational
cannabis retail stores, Meta Growth enables the public to gain
knowledgeable access to Canada's
network of authorized Licensed Producers of cannabis. National
Access Cannabis d/b/a Meta Growth is listed on the TSX Venture
Exchange under the symbol (TSXV: META).
For more information on Meta Growth, visit:
metagrowth.com
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Cautionary Statements
This news release contains
forward-looking statements and forward-looking information within
the meaning of applicable securities laws. The use of any of the
words "expect", "anticipate", "continue", "estimate", "objective",
"ongoing", "may", "will", "project", "should", "believe", "plans",
"intends" and similar expressions are intended to identify forward
looking statements or information. Forward-looking statements and
information in this news release includes, but is not limited to,
any potential sale, in whole or in part, of META's medical clinic
division. Although the Company believes that the expectations and
assumptions on which the forward-looking statements and information
are based are reasonable, undue reliance should not be placed on
the forward-looking statements and information because the Company
cannot give any assurance that they will prove to be correct. Since
forward-looking statements and information address future events
and conditions, by their very nature they involve inherent risks
and uncertainties. Actual results and developments may differ
materially from those that are currently contemplated by these
statements depending on, among other things, risks relating to
future legislative and regulatory developments; ability to find an
appropriate purchaser for the medical clinic division, the ability
of any purchaser to complete closing, inability to access
sufficient capital from internal and external sources, and/or
inability to access sufficient capital on favourable terms; general
business, economic, competitive, political, regulatory and social
uncertainties; the delay or failure to receive regulatory approvals
and the recreational cannabis industry in Canada generally. The Company cautions that
the foregoing list of risks and uncertainties is not exhaustive.
The forward-looking statements and information contained in this
news release are made as of the date hereof and the Company
undertakes no obligation to update publicly or revise any
forward-looking statement or information, whether as a result of
new information, future events or otherwise, unless so required by
applicable securities laws.
1 New Cannabis Ventures, Public
Cannabis Company Revenue & Income Tracker. Largest publicly
traded cannabis retailer by revenue.
SOURCE National Access Cannabis Corp d/b/a Meta Growth